a company pioneering enzyme and targeted drug design to power the next wave of precision medicines.
Ridge Biotechnologies has raised $25.0M in total funding. The most recent round was Seed. The last funding was announced in September 2025.
Ridge Biotechnologies's investors include Overlap Holdings, Sutter Hill Ventures.
Ridge Biotechnologies is headquartered in Palo Alto, United States.
a company pioneering enzyme and targeted drug design to power the next wave of precision medicines.
Ridge Biotechnologies is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Ridge Biotechnologies — Funding & Investors." VCBacked, September 9, 2025, https://www.vcbacked.co/company/ridge-biotechnologies. Accessed September 15, 2026.
VCBacked. (2025). Ridge Biotechnologies — Funding & Investors. Retrieved September 15, 2026, from https://www.vcbacked.co/company/ridge-biotechnologies
{{cite web |title=Ridge Biotechnologies — Funding & Investors |url=https://www.vcbacked.co/company/ridge-biotechnologies |website=VCBacked |access-date=September 15, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated